Cambridge Trust Co. boosted its position in Clorox Co (NYSE:CLX) by 8.3% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 11,624 shares of the company’s stock after acquiring an additional 895 shares during the period. Cambridge Trust Co.’s holdings in Clorox were worth $1,865,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Athena Capital Advisors LLC bought a new position in Clorox in the fourth quarter valued at about $25,000. Meeder Asset Management Inc. bought a new position in Clorox in the fourth quarter valued at about $26,000. Capital Financial Planning LLC bought a new position in Clorox in the fourth quarter valued at about $32,000. Paragon Capital Management LLC bought a new position in Clorox in the first quarter valued at about $35,000. Finally, City Holding Co. boosted its holdings in Clorox by 150.0% in the fourth quarter. City Holding Co. now owns 250 shares of the company’s stock valued at $39,000 after acquiring an additional 150 shares during the last quarter. Institutional investors and hedge funds own 76.90% of the company’s stock.

A number of equities analysts have issued reports on the company. Zacks Investment Research cut Clorox from a “hold” rating to a “sell” rating in a report on Tuesday, April 9th. Barclays restated a “hold” rating and set a $142.00 target price on shares of Clorox in a report on Wednesday, February 6th. BMO Capital Markets set a $175.00 target price on Clorox and gave the stock a “buy” rating in a report on Tuesday, February 5th. Credit Suisse Group assumed coverage on Clorox in a report on Wednesday, March 6th. They set an “outperform” rating and a $172.00 target price on the stock. Finally, Wells Fargo & Co restated a “hold” rating and set a $157.00 target price on shares of Clorox in a report on Thursday, February 21st. Six research analysts have rated the stock with a sell rating, five have assigned a hold rating and four have issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $151.21.

In other Clorox news, SVP Andrew J. Mowery sold 5,340 shares of the business’s stock in a transaction that occurred on Friday, March 1st. The stock was sold at an average price of $156.44, for a total transaction of $835,389.60. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, SVP Matthew T. Laszlo sold 10,585 shares of the business’s stock in a transaction that occurred on Wednesday, February 6th. The stock was sold at an average price of $153.89, for a total value of $1,628,925.65. Following the transaction, the senior vice president now directly owns 17,994 shares in the company, valued at approximately $2,769,096.66. The disclosure for this sale can be found here. 1.40% of the stock is owned by insiders.

Shares of Clorox stock opened at $153.48 on Monday. Clorox Co has a 52-week low of $113.57 and a 52-week high of $167.70. The company has a market capitalization of $19.67 billion, a P/E ratio of 24.52, a PEG ratio of 3.98 and a beta of 0.32. The company has a current ratio of 1.15, a quick ratio of 0.66 and a debt-to-equity ratio of 3.08.

Clorox (NYSE:CLX) last announced its earnings results on Monday, February 4th. The company reported $1.40 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.32 by $0.08. The business had revenue of $1.47 billion for the quarter, compared to analyst estimates of $1.47 billion. Clorox had a return on equity of 105.97% and a net margin of 12.65%. Clorox’s revenue for the quarter was up 4.0% compared to the same quarter last year. During the same quarter last year, the firm earned $1.77 EPS. Research analysts forecast that Clorox Co will post 6.3 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th will be given a dividend of $0.96 per share. This represents a $3.84 annualized dividend and a dividend yield of 2.50%. The ex-dividend date is Tuesday, April 23rd. Clorox’s dividend payout ratio (DPR) is 61.34%.

TRADEMARK VIOLATION NOTICE: This article was published by Watch List News and is the property of of Watch List News. If you are accessing this article on another site, it was illegally copied and republished in violation of US & international copyright & trademark legislation. The original version of this article can be viewed at https://www.watchlistnews.com/cambridge-trust-co-increases-stake-in-clorox-co-clx/2981140.html.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Featured Story: Cost of Debt

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.